top of page

INVEGA Sustenna Prolonged Release Suspension for IM Injection 50mg/0.5 ml

Product details

Registration number: SIN13969P

Classification: Prescription Only

Active ingredients: Paliperidone palmitate 78 mg eqv Paliperidone

Strength: 50mg/0.5ml

Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE

Route: INTRAMUSCULAR

Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

ATC code: N05AX13

HSA approval date: 13 June 2011

Manufacturer(s):

  • Janssen Pharmaceutica N.V.,
  • Cilag AG

Manufacturing country/countries: SWITZERLAND; BELGIUM

What are the HSA registration number and classification for INVEGA Sustenna Prolonged Release Suspension for IM Injection 50mg/0.5 ml?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN13969P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for INVEGA Sustenna Prolonged Release Suspension for IM Injection 50mg/0.5 ml?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Paliperidone palmitate 78 mg eqv Paliperidone

Strength: 50mg/0.5ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for INVEGA Sustenna Prolonged Release Suspension for IM Injection 50mg/0.5 ml?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for INVEGA Sustenna Prolonged Release Suspension for IM Injection 50mg/0.5 ml?

According to the HSA dataset updated 7 August 2026:

Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for INVEGA Sustenna Prolonged Release Suspension for IM Injection 50mg/0.5 ml?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Janssen Pharmaceutica N.V.,
  • Cilag AG

Manufacturing country/countries: SWITZERLAND; BELGIUM

Source for this answer

Where can I look up INVEGA Sustenna Prolonged Release Suspension for IM Injection 50mg/0.5 ml in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN13969P or the exact product name INVEGA Sustenna Prolonged Release Suspension for IM Injection 50mg/0.5 ml. The general register link does not preselect this product.

Source for this answer

What are the source dates for this INVEGA Sustenna Prolonged Release Suspension for IM Injection 50mg/0.5 ml record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this INVEGA Sustenna Prolonged Release Suspension for IM Injection 50mg/0.5 ml record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN13969P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page